BRIEF

on MicroGenDX

MicroGenDX Launches New Patient-Focused Website to Enhance Access to Microbial Testing

MicroGenDX, the leader in clinical Next Generation DNA Sequencing (NGS) tests, announced the launch of a redesigned website aimed at improving patient access to microbial diagnostic products. This new platform is developed with a strong patient-centric approach to simplify the discovery and understanding of medical tests.

The website facilitates users to navigate and opt for microbial testing relevant to both clinical diagnosis and lifestyle purposes. With the aim of reducing the complexity of medical diagnostics, the site includes enhanced navigation that allows users to learn about, select, and receive their tests in as few as three clicks. This effort underscores MicroGenDX's commitment to providing user-friendly digital tools that empower patients with knowledge about their health options.

The design of the website focuses on streamlining patient experiences during test selection and purchase, offering comprehensive education materials, and simplifying test collection and submission processes. This transformation marks MicroGenDX’s expansion of its services into direct-to-patient applications, addressing a broad range of microbial testing requirements.

R. H.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all MicroGenDX news